Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v1-EN
Language French English
Date Updated 2018-03-13 2017-05-10
Drug Identification Number 02250497 02250497
Brand name TEVA-AMLODIPINE TEVA-AMLODIPINE
Common or Proper name AMLODIPINE AMLODIPINE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-05-04 2017-05-04
Estimated end date 2018-01-30 2017-08-25
Actual end date 2018-02-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments